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 The constant or repeated unprotected exposure to solar radiation can result in the onset of various harmful 
effects, such as inflammation, genetic mutation and hyperpigmentation, even than previous photoaging. 
The use of photoprotective formulations is one of the most effective tools to avoid this. However, most of 
the UV filters are unstable to UV radiation, can even permeate the skin and cause hepatotoxic effects. The 
aim of this study was to assess the efficacy and safety of an innovative sunscreen substance (E) -4- (tert-
butyl) -N '- ((E) -3- (4-methoxyphenyl) allylidene) benzhydrazide. Methods: The sunscreen formulation 
containing the innovative substance was subjected to various stress conditions: 45±2° C, 5±2° C and 
exposure to sunlight. These samples were evaluated in relation to its rheology, pH, viscosity, density and 
SPF to determine its stability. The assessment of TBMAB release from the formulation was performed in 
Microette equipment. Hepatoma cells (HepG2) were used to determine the TBMAB cytotoxicity. Results 
and Discussion: In the stability study, no significant changes were observed in the formulation. The 
maximum concentration of TBMAB released from the formulation was 3.63 µg.cm-2. Also, it was evident 
the cytotoxic effect on the concentrations well above 3.63 µg.cm-2, displaying the safety of this substance, 
considering HepG2 cells. Conclusion: These results demonstrate that TBMAB is a suitable innovative 
substance to be used in suscreens, exhibiting stability, desired SPF value and safety, considering HepG2 
cells. Thus, it could be a new alternative to prevent skin cancer.
Eficácia e segurança de filtros solares inovadores (E) -4- (TERT-BUTIL) -N '- ((E) -3- 
(4-METOXIFENIL) ALILIDENO) BENZIDRAZIDA (TBMAB)
A exposição constante e/ou repetida e desprotegida à radiação solar pode resultar no aparecimento de 
vários efeitos nocivos, como inflamação, mutação genética, hiperpigmentação e, até mesmo, o fotoenve-
lhecimento. O uso de formulações fotoprotetoras é uma das ferramentas mais eficazes para evitar estes 
efeitos deletérios. No entanto, a maioria dos filtros solares é instável à radiação UV, pode permear a pele e 
causar efeitos hepatotóxicos. O objetivo deste estudo foi avaliar a eficácia e a segurança de uma substância 
fotoprotetora inovadora (E) -4- (terc-butil) -N '- ((E) -3- (4-metoxifenil) alilideno) benzidrazida. Métodos: 
A formulação de filtro solar contendo a substância inovadora foi submetida a várias condições de estresse: 
45 ± 2°C, 5 ± 2°C e exposição à luz solar. Essas amostras foram avaliadas em relação à sua reologia, pH, 
viscosidade, densidade e FPS para determinar sua estabilidade. A avaliação da liberação de TBMAB à 
partir da formulação foi realizada em equipamentos Microette. As células de hepatoma (HepG2) foram 
usadas para determinar a citotoxicidade do TBMAB. Resultados e Discussão: No estudo de estabilidade, 
não foram observadas alterações significativas na formulação. A concentração máxima de TBMAB liberada 
a partir da formulação foi de 3.63 µg.cm-2. Também ficou evidente o efeito citotóxico nas concentrações 
acima de 3.63 µg.cm-2, demonstrando a segurança dessa substância, considerando as células HepG2. 
Conclusão: Esses resultados demonstram que o TBMAB é uma substância inovadora adequada para ser 
usada na fotoproteção, exibindo estabilidade, valor desejado de SPF e segurança, considerando as células 
HepG2. Assim, poderia ser uma nova alternativa para prevenir o câncer de pele.
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Introduction 
The constant and  repeated unprotected exposure to sun radiation can result in the onset of various 
harmful effects, such as inflammation, genetic mutation, hyperpigmentation, photoaging and, inclusive, 
induction of malignant tumors (RASS; REICHRATH, 2008; REIS JUNIOR et al., 2016). The number of 
skin cancers increased 77 % between 1992 and 2006, in the US, as a result of the constant exposure to 
sun radiation and destruction of the ozone layer (SIEGEL; MILLER; JEMAL, 2015).
Skin cancer is classified at melanoma and non-melanoma cancers. The melanoma is  related with higher 
occurrence of genetic mutation and metastasis (ARMSTRONG; KRICKER, 2001; BOUKAMO, 1999; 
DENNIS; BEANE FREEMAN; VANBEEK, 2003) being dependent of the time and intensity of exposure 
to solar radiation (GRUIJL, 1999; GORDON, 2013). The non-melanoma reaches basal cells (is the most 
frequent) (SIEGEL; MILLER; JEMAL, 2015; SOEHNGE; OUHTIT; ANANTHASWAMY, 1997).   
The use of sunscreens is the most efficient tool of skin cancer prevention (BOUKAMP, 1999; WRIGHT; 
SPENCER; FLOWERS, 2006). However, most of the UV filters are unstable to UV radiation, can even 
permeate skin and cause adverse effects such as contact dermatites, allergic reaction, mutation and toxicity 
(REIS JUNIOR et al., 2016). Avobenzone is one of the filters with the highest photoprotection against UVA 
radiation however, this compound has adverse effects such as: photoinstability and incompatibility with 
other sunscreens. Ethylhexyl p-methoxycinnamate is one of the filters with the highest photoprotection 
against UVB radiation however, this compound presents photoinstability (BERNEBURG; PLETTEN-
BERG; KRUTMANN, 2000; WRIGHT; SPENCER; FLOWERS, 2006; SIEGEL; MILLER; JEMAL, 2015). 
In previous experiments performed in the Laboratory of Pharmaceutical Chemistry of UNESP, were 
synthesized 8 active compounds with protection capacity against UVA and UVB radiation. The compound 
(E) -4- (tert-butyl) -N '- ((E) -3- (4-methoxyphenyl) allylidene) benzidrazida - TBMAB was obtained by 
molecular hybridization of the pharmacophoric groups of Avobenzone with octyl methoxycinnamate and 
showed higher activity photoprotective in relation to the other synthesized compounds (REIS JUNIOR 
et al., 2016). Thus, the aim of this study was to assess the efficacy and safety of an innovative sunscreen 
(E) -4- (tert-butyl) -N '- ((E) -3- (4-methoxyphenyl) allylidene) benzidrazida – TBMAB.
Methods
Synthesis of TBMAB
The TBMAB synthesis (Figure 1) was performed according to the methods described by Reis (REIS 
et al., 2014).
Figure 1 - Synthesis of TBMAB.
 
Source: (REIS et al., 2014).
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 Development of sunscreen formulation
Table 1 shows the components of the sunscreen formulation. A sunscreen formulation should be 
stable at different temperatures and conditions without the occurrence of degradation of formulation 
components, mainly the active compound.
Table 1 - Composition of the sunscreen formulation.
INCI name %
Helianthus Annuus (Sunflower) Seed Oil (and) Sodium Polyacrylate (and) 
Xylitol (and) Caprylic Acid (and) Glyceryl Stearate
4
Dibutyl Adipate 2
Alkyl Benzoate C12-15 5
Caprylic/Capric Triglyceride 4




Green coffee oil 2
Aqua qsp 100
Assessment of the formulation stability
TThe sunscreen formulation was subjected to various stress conditions: 45±2° C, 5±2° C and exposure 
to sunlight. During 90 days, SPF, PFUVA, pH and rheology was measured periodicaly (ISAAC et al., 2008).
  
 SPF and PFUVA in vitro (Optometrics) assessment
The sunscreen formulation (0.11 g) was spread on a Transpore® tape. Measurements were performed 
in the Optometrics SPF 290 equipament, a spectrophotometer with detection via integrating sphere. The 
SPF (sun protection factor) and PFUVA (UVA protection factor) values were determined. Readings were 
made in the range of 290 nm to 400 nm in triplicate. The control was prepared using the emulsion without 
TBMAB (DUTRA et al., 2004).
 pH assessement
The sunscreen formulation was dispersed in distilled water (10% w/w) for pH determination. The 
pH values need to be between 5.5 and 6.5, which are compatible with the skin pH (ISAAC et al., 2008)..
Rheology measurements
The rheology measurements were performed in a Brookfield rheometer using the cone-plate type se-
The rheology measurements were performed in a Brookfield rheometer using the cone-plate type sensor 
(C40 / 2° Ti). The data were analyzed by the software Rheowin 3. All assays were performed in triplicate, 
at a temperature of 32 ± 1 °C.  
The viscosity and flow properties were determined by application of a shear rate, from 0 – 100 s-1 for 
120 seconds to ascending curve followed by a shear rate of 100 – 0 s-1 for 120 seconds to descending 
curve (ISAAC et al., 2008; GALLEGOS; FRANCO, 2011).
The creep and relaxation assay was obtained using a shear stress of 1 Pa for 300 seconds and, after, 
accompanying the recovery for over 300 seconds, ceasing the applied tension (ISAAC et al., 2008; 
GALLEGOS; FRANCO, 2011).
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TBMAB release
The release of TBMAB from the sunscreen formulation was studied in a Microette equipment. Modified 
Franz cells were used, with 1.77 cm2 of diffusion area, and cellulose membrane  (Sigma-Aldrich) (FRANZ, 
1975).  The Modified Franz cell compartment was filled with 7.0 mL of 0.1 M phosphate buffer (pH 7.4) 
and ethoxylated sorbitan monooleate surfactant 20OE (3%) at a temperature of 32 ± 5 ° C and stirring 
at 300 rpm (LEHMAN; RANEY; FRANZ, 2011). Samples of 295 mg of the sunscreen formulation were 
placed on the cellulose membrane (FRANZ, 1975). The amount of active released was quantified by UV 
spectrophotometry after 2, 4, 6, 8 and 12 hours of testing (ANVISA, 2003).
Cytotoxicity assays
The degree of cytotoxicity was determined by MTT assay. In this assay, living cells are able to reduce 
3- (4,5-dimethyl-2-thiazolyl) -2,5-diphenyl-2H-tetrazolium bromide (MTT), forming violet formazan 
crystals (MOSMANN, 1983). The hepatoma cells (HepG2) were cultured in DMEM and treated with 
different concentrations of TBMAB. The cell density for the cytotoxicity test (MTT) was 1 x 105 cells.
mL-1. After treatment, spectrophotometric reading was performed in microplate reader in a wavelength 
of 595 nm (ABE; MATSUKI, 2000). As positive control, DMSO 10% were employed and the negative 
control was DMEM. 
 
Statistical analysis 
All results were subjected to statistical analysis of variance test using the ANOVA and Tukey test for 
multiple comparisons of average. The resulting values equal to or less than 5% was considered statistically 
significant (STHLE; WOLD, 1989).
Results and discussion
SPF and PFUVA in vitro (Optometrics) assessment
The sun protection factor (SPF) and PFUVA assessment help in the determination of the activity and 
of the possible degradation of the sunscreen formulation constituents. Through Tukey test, was evidenced 
no significant difference, both in the SPF (Figure 2) and PFUVA (Figure 3) between the control sunscreen 
formulation (5 ± 2 °C) and the formulations subjected to physical stress (45 ± 2 °C and exposure to 
sunlight). These results indicate that the sunscreen active is stable under increased temperature and/or 
exposure to sunlight (SPRINGSTEEN et al., 1999). 
Figure 2 - SPF values for 90 days.
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A higher SPF compared to PFUVA may be related to the caffeine's ability to increase the SPF of some 
chemical filters, justified by its UVB absorption capacity (SHEHATA; RIZK; REND, 2016). This synergistic 
capacity of the green coffee oil is due to the possibility of intermolecular hydrogen bonds, which can occur 
between a pair of electrons free of caffeine and the functional clusters of the tested solar filter (LEONE, 2018).
The same comparison was done in relation to the PFUVA of the formulations, and no diferences were 
verified between the sample maintained at 5 ºC and the formulations subjected to physical stress (45 ± 
2 °C and exposure to sunlight).
Figure 3 - Assay PFUVA.
  pH assessment
When pH reduces to values below to 5.5 they can be related to the degradation of the constituents of the 
formulation. Also, it can cause dermal irritation. Thus, during the stability studies, the maintenance of pH 
values between 5.5 and 6.5 was observed. Furthermore, no significant differences in the pH values were 
evidenced (Figure 4) between the control sunscreen formulation (5 ± 2 °C) and the samples exposed to 
physical stress (45 ± 2 °C and exposure to sunlight). These results, once again, indicate that the sunscreen 
formulation is stable under increased temperature and/or exposure to sunlight (ANVISA, 2004; CORRÊA, 
2012).    
Figure 4 - pH values measured during 90 days.
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Rheology measurements
Flow properties
The rheogram showed on Figure 5 demonstrated that does not exist linear relationship between shear 
stress and shear rate values, specifying the non-Newtonian behavior of the sunscreen formulations. This 
type of non-Newtonian behavior is fitted by the Herschel-Bulkley model (GALLEGOS; FRANCO, 1999; 
ALVES, 2004; BARRY; WARBURTON, 1968), where the flow occurs only from a specific shear stress 
depending of a yield stress (T 0) that should be exceeded. 
Figure 5 - Flow properties measurements.
The hysteresis area is defined as the area between the ascendent (0-100s-1) and the descendent (100-
0s-1) flow curves. Thus, we could consider that how much higher is the difference between the hysteresis 
areas of the formulations subjected to different stress conditions, higher is the instability of the sunscreen 
formulation. Through Tukey test, was evidenced no significant difference of the hysteresis area between 
the control formulation (5 ± 2 °C) and the formulations under physical stress (45 ± 2 °C, exposure to 
sunlight). These results indicate that the sunscreen formulation is stable under increased temperature and 
/ or exposure to sunlight (GALLEGOS; FRANCO, 1999; ALVES, 2004; BARRY; WARBURTON, 1968).  
Viscosity
According to the results (Figure 6), all samples showed a decrease in viscosity with increasing shear rate.
Figure 6 - Assay viscosity.
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This rheological behavior is related deformation, random orientation and / or disaggregation of mo-
lecules for to facilitate flow. There was no significant difference between the viscosity of sunscreen for-
mulations under different physical stresses (45 ± 2 °C or exposure sunlight) and the control sample (5 ± 
2 °C) (GALLEGOS; FRANCO, 1999; ALVES, 2004; BARRY; WARBURTON, 1968).
Creep and relaxation
During the application of shear stress (0-300 sec), the elastic properties (creep) of the sunscreen for-
mulation is observed. After ceasing the shear stress (300-600 sec), the viscous behavior of the material 
(relaxation) can be observed (Figure 7) (GALLEGOS; FRANCO, 1999; ALVES, 2004; BARRY; WAR-
BURTON, 1968).
Figure 7 - Creep and relaxation assay.
Thus, the sunscreen formulations subjeted to various physical stress conditions (5 ± 2 °C, 45 ± 2 °C 
and exposure to sunlight), had not presented significant differences, indicating that the sunscreen for-
mulation is stable under different temperatures (GALLEGOS; FRANCO, 1999; ALVES, 2004; BARRY; 
WARBURTON, 1968).
Scan analysis by spectrophotometry UV 
The phosphate buffer (0.1 M - pH 7.4) with sorbitan monooleate surfactant ethoxylated EO 20 (3%) 
was used as solvent for determination the maximum absorption wavelength of TBMAB. According to 
the results, the maximum absorption wavelength is λ=338 nm (ANVISA, 2003).  
 
TBMAB release
The TBMAB release was quantified by means of UV spectrophotometry after 2, 4, 6, 8 and 12 hours of 
testing. According to the results (Figure 8), the maximum concentration of TBMAB released occurred 
after 12 hours (4,05 µg/cm2). There was no significant difference (p<0,05) of sunscreen active released 
after 8 and 12 hours (Tukey test) (FRANZ, 1975).
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Figure 8 - TBMAB released after 2, 4, 6, 8 and 12 hours.
Cytotoxicity assays
In this essay (Figure 9), it was evidenced that the active sunscreen in a concentration of 0.00022321 
g.mL-1, increased cell viability (16.17%) compared to control group. However, it was evident cytotoxic 
effect in concentrations higher than 0.00022321 g.mL-1 (MOSMANN, 1983; ABE; MATSUKI, 2000). The 
use of the HepG2 strain is functional to assess the xenobiotic potential if the studied compound crosses 
the skin barrier. The liver is an important xenobiotic metabolizer, so analyzing the cytotoxic potential for 
this organ is extremely important (ATES et al., 2014; ATES et al., 2017; VINHAL et al., 2020). 
Figure 9 - Cytotoxicity assay of TBMAB.
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Conclusion 
In the stability study, no significant changes were observed in the formulation. The average SPF of 
the sunscreen formulation was 3.5. The maximum concentration of active released was 3.63 µg.cm-2. In 
the assay of hepatotoxicity, was observed that the active sunscreen increased cell viability by 16.17% at a 
concentration of 0.223 g.mL-1 on comparison to control group; however, it was evident cytotoxic effect 
on the concentrations well above 0.223 g.mL-1.    
These results demonstrate that this sunscreen formulation is safe and effective and endorse the possibility 
of this asset be promising prototype of a new class of sunscreens to prevent skin cancer. 
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